IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 168 filers reported holding IMMUNITYBIO INC in Q1 2024. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $8,317,196 | +8.3% | 1,548,826 | +1.2% | 0.01% | +14.3% |
Q4 2023 | $7,680,138 | +196.2% | 1,529,908 | -0.3% | 0.01% | +133.3% |
Q3 2023 | $2,592,692 | -8.3% | 1,534,137 | +50.9% | 0.00% | 0.0% |
Q2 2023 | $2,825,854 | +74.5% | 1,016,494 | +14.3% | 0.00% | +50.0% |
Q1 2023 | $1,619,253 | -53.7% | 889,699 | +29.0% | 0.00% | -50.0% |
Q4 2022 | $3,496,951 | +0.8% | 689,734 | -1.2% | 0.00% | 0.0% |
Q3 2022 | $3,469,000 | +35.5% | 698,052 | +1.4% | 0.00% | +33.3% |
Q2 2022 | $2,561,000 | -0.2% | 688,474 | +50.5% | 0.00% | +50.0% |
Q1 2022 | $2,566,000 | -2.0% | 457,475 | +6.2% | 0.00% | +100.0% |
Q4 2021 | $2,619,000 | -31.3% | 430,754 | +10.0% | 0.00% | -50.0% |
Q3 2021 | $3,815,000 | +50.1% | 391,661 | +120.0% | 0.00% | +100.0% |
Q2 2021 | $2,542,000 | -41.2% | 178,025 | -2.2% | 0.00% | -50.0% |
Q1 2021 | $4,323,000 | – | 182,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |